FDA.reportPublic FDA data

← NDC directory

FDA compounder NDC directory

Browse every current FDA compounder source row, including records that do not contain a usable NDC.

Compounder NDC directory#

Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.

Compounder directory page 1 of 1 · 7 matching rows.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCBrandNonproprietary nameActive ingredientsPeriodNormalizationSource date
Empower Pharmacy83117894772627-250472627-2504-3Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL2022-1valid2026-10-20
Empower Pharmacy83117894772627-250472627-2504-3Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL2021-2valid2026-10-20
Empower Pharmacy83117894772627-250472627-2504-3Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL2021-1valid2026-10-20
Empower Pharmacy83117894772627-250472627-2504-3Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL2020-2valid2026-10-20
Empower Pharmacy83117894772627-250472627-2504-3Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL2020-1valid2026-10-20
Empower Pharmacy83117894772627-250472627-2504-3Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL2019-2valid2026-10-20
Empower Pharmacy83117894772627-250472627-2504-3Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 4 mg/1 mL; .04 mg/1 mL; .4 mg/1 mL2019-1valid2026-10-20